RecruitingPhase 3NCT03150693
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With Newly Diagnosed B Acute Lymphoblastic Leukemia
Sponsor: Alliance for Clinical Trials in Oncology
Aurora, CO · Boulder, CO · +452 more sites
Leukemia clinical trials in Denver, CO
13 recruiting leukemia studies with a site in Denver, CO.
RecruitingPhase 3NCT06136559
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Sponsor: Merck Sharp & Dohme LLC
Denver, CO · Golden, CO · Grand Junction, CO · +46 more sites
RecruitingPhase 3NCT07007312
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Sponsor: Kura Oncology, Inc.
Aurora, CO · Denver, CO · +42 more sites
RecruitingPhase 2NCT06514794
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
Sponsor: Allotera Therapeutics
Denver, CO · +15 more sites
RecruitingPhase 3NCT04293562
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Sponsor: Children's Oncology Group
Aurora, CO · Denver, CO · +184 more sites
RecruitingPhase 2NCT07221500
A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)
Sponsor: Nurix Therapeutics, Inc.
Denver, CO · +26 more sites
RecruitingPhase 2 / Phase 3NCT03013998
Study of Biomarker-Based Treatment of Acute Myeloid Leukemia
Sponsor: Beat AML, LLC
Denver, CO · +30 more sites
RecruitingPhase 1 / Phase 2NCT04726241
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Sponsor: PedAL BCU, LLC
Aurora, CO · Denver, CO · +162 more sites
RecruitingPhase 1NCT06001788
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Sponsor: Kura Oncology, Inc.
Denver, CO · +37 more sites
RecruitingPhase 1NCT05131022
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Sponsor: Nurix Therapeutics, Inc.
Denver, CO · +17 more sites
RecruitingPhase 1 / Phase 2NCT04988555
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
Sponsor: Sumitomo Pharma America, Inc.
Denver, CO · +32 more sites
RecruitingPhase 1NCT05780034
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
Sponsor: Accutar Biotechnology Inc
Denver, CO · +8 more sites
RecruitingPhase 1 / Phase 2NCT04150497
Phase 1/2 Study of UCART22 in Patients With Relapsed or Refractory CD22+ B-cell Acute Lymphoblastic Leukemia (BALLI-01)
Sponsor: Cellectis S.A.
Aurora, CO · Denver, CO · +12 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.